GRNA - GreenLight Biosciences draws private equity interest; up 10%

2023-03-30 16:55:04 ET

• GreenLight Biosciences ( NASDAQ: GRNA ) is up ~10% in after-hours trading after confirming that a private equity fund is interested in the company.
• The RNA biotech company said it received a non-binding indication of interest from Fall Line Endurance Fund to acquire all GreenLight ( GRNA ) common stock for $0.60 per share.
• The company's shares closed Thursday at $0.44 per share.
• GreenLight said its board will evaluate Fall Line's interest through a special committee.
• Seeking Alpha's Quant Rating views GreenLight ( GRNA ) as a strong sell.

For further details see: